IXC 10.0% 6.3¢ invex therapeutics ltd

Ann: Trading Halt, page-12

  1. 2,924 Posts.
    lightbulb Created with Sketch. 1297

    I'm guessing Invex has the required funds to run a ph3 trial, however the collaboration could be with AstraZeneca or BMS to manufacture and supply Exenatide/Presendin for free. It would then have to have some time of partnership/deal for if it reaches certain milestones.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
-0.007(10.0%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 6.3¢ $4.485K 65.57K

Buyers (Bids)

No. Vol. Price($)
1 50000 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8695 1
View Market Depth
Last trade - 11.20am 20/08/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.